Helgadottir H - Search Results

1

Declining invasive and rising in situ melanoma incidence trends in Iceland: A nationwide cohort study.

Thomas S, Hoyt D, Stoddard G, Snyder AM, Andradottir E, Grant-Kels JM, Ungar J, Lewin JM, Gulati N, Jonasson JG, Sigurdsson H, Helgadottir H, Adalsteinsson JA. Thomas S, et al. Among authors: helgadottir h. J Eur Acad Dermatol Venereol. 2024 Oct 24. doi: 10.1111/jdv.20386. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 39444324

2

Melanoma-specific survival before and after inclusion in a familial melanoma dermatologic surveillance program in CDKN2A mutation carriers and non-carriers.

Pissa M, Lapins J, Sköldmark C, Helgadottir H. Pissa M, et al. Among authors: helgadottir h. J Eur Acad Dermatol Venereol. 2023 Feb;37(2):284-292. doi: 10.1111/jdv.18589. Epub 2022 Oct 1. J Eur Acad Dermatol Venereol. 2023. PMID: 36156317 Free PMC article.

3

Melanoma susceptibility genes in paediatric melanoma and differences in children or adolescents and sporadic or familial cases.

Helgadottir H. Helgadottir H. J Eur Acad Dermatol Venereol. 2022 Feb;36(2):167-168. doi: 10.1111/jdv.17879. J Eur Acad Dermatol Venereol. 2022. PMID: 35037305 No abstract available.

4

Melanoma Incidence and Mortality Trends Among Patients Aged 59 Years or Younger in Sweden.

Helgadottir H, Mikiver R, Schultz K, Nielsen K, Portelli F, Lapins J, Puig S, Isaksson K. Helgadottir H, et al. JAMA Dermatol. 2024 Nov 1;160(11):1201-1210. doi: 10.1001/jamadermatol.2024.3514. JAMA Dermatol. 2024. PMID: 39245436 Free PMC article.

5

Multiple Primary Melanoma Incidence Trends Over Five Decades: A Nationwide Population-Based Study.

Helgadottir H, Isaksson K, Fritz I, Ingvar C, Lapins J, Höiom V, Newton-Bishop J, Olsson H. Helgadottir H, et al. J Natl Cancer Inst. 2021 Mar 1;113(3):318-328. doi: 10.1093/jnci/djaa088. J Natl Cancer Inst. 2021. PMID: 32577730 Free PMC article.

6

Survival after introduction of adjuvant treatment in stage III melanoma: a nationwide registry-based study.

Helgadottir H, Ny L, Ullenhag GJ, Falkenius J, Mikiver R, Olofsson Bagge R, Isaksson K. Helgadottir H, et al. J Natl Cancer Inst. 2023 Sep 7;115(9):1077-1084. doi: 10.1093/jnci/djad081. J Natl Cancer Inst. 2023. PMID: 37227040 Free PMC article.

7

Does the Germline Genome Encode for the Invasiveness of a Cutaneous Melanoma?

Helgadottir H. Helgadottir H. JAMA Dermatol. 2024 Sep 1;160(9):922-924. doi: 10.1001/jamadermatol.2024.2599. JAMA Dermatol. 2024. PMID: 39141377 No abstract available.

8

Cancer risks and survival in patients with multiple primary melanomas: Association with family history of melanoma and germline CDKN2A mutation status.

Helgadottir H, Tuominen R, Olsson H, Hansson J, Höiom V. Helgadottir H, et al. J Am Acad Dermatol. 2017 Nov;77(5):893-901. doi: 10.1016/j.jaad.2017.05.050. Epub 2017 Aug 14. J Am Acad Dermatol. 2017. PMID: 28818438

9

Personalized Medicine in Malignant Melanoma: Towards Patient Tailored Treatment.

Helgadottir H, Rocha Trocoli Drakensjö I, Girnita A. Helgadottir H, et al. Front Oncol. 2018 Jun 12;8:202. doi: 10.3389/fonc.2018.00202. eCollection 2018. Front Oncol. 2018. PMID: 29946532 Free PMC article. Review.

10

[The melanoma incidence continues to rise].

Helgadottir H, Stierner U. Helgadottir H, et al. Lakartidningen. 2017 May 9;114:ELAP. Lakartidningen. 2017. PMID: 28485765 Free article. Swedish. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

151 results

Search Page

Filters